Consumer Behavior
CPG Reformulates for the GLP-1 Shopper
Smaller portions, higher protein, lower sugar: brands chase the 12% of America on GLP-1s.
By FTF Editorial Team·May 20, 2026·5 min read
With an estimated 12% of US adults now on GLP-1 medications, major snack brands are reformulating around smaller portions, higher protein, and slow-digesting carbs.
What happened
Nestlé launched the Vital Pursuit line of GLP-1-targeted frozen meals in 2024 and tripled SKUs in 2026. General Mills reformulated Yoplait's high-protein line to add 4g of protein per serving. Snack-bar category leaders Kind and RXBar both released 'satiety' lines in Q1.
Why it matters
GLP-1 users eat 20-30% fewer calories but spend MORE per calorie on protein-dense, nutrient-dense foods. The category isn't shrinking; it's premiumizing. Brands that ignore this demographic risk a slow-bleed scenario over 5-10 years.
Market impact
Expect every major CPG to have a GLP-1-targeted SKU portfolio by end of 2026. Snack-cake, candy, and salty-snack categories will see permanent volume declines of 4-8%; protein, dairy, and produce will absorb the spend.
Consumer insight
GLP-1 users don't self-identify as a demographic in market research: they describe themselves by behavior ('I eat smaller meals now'). Reach them through outcome messaging, not medication messaging.
Strategic takeaway
If your brand is in a calorie-dense indulgence category, your 2030 plan needs a smaller-format, higher-protein hero SKU now. Two-year reformulation cycles are too slow.
Get the next signal in your inbox.
Daily food industry intelligence — free.
You've reached the end.